Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts Details-
Title Grant Type Focus Area Country Application Due Date Improving Shared Decision Making in Hemophilia: Visiting Professorship Program - 2026, Semester 2Release Date:Partner: Hemostasis & Thrombosis Research Society (HTRS)Education Rare Disease USA The Role of RSV in Functional Decline and Healthcare Dependency in Hospitalized AdultsRelease Date:Research Vaccines Italy Improving the Quality and Standardization of Pneumococcal Diagnostic Pathways in Pediatric and Adult PopulationsRelease Date:Quality Improvement Vaccines Italy 2026 VAC US SMFM Maternal RSV QIRelease Date:Partner: Society for Maternal Fetal MedicineQuality Improvement Vaccines USA Evolving Treatment Options in First-Line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)Education Oncology All Implementing Germline and Somatic Testing for Precision Medicine in Community-Based Prostate Cancer Care: Visiting ProfessorshipRelease Date:Partner: Prostate Cancer FoundationEducation Oncology USA New Mechanisms and Emerging Treatment Options in Metastatic Castration Resistant Prostate Cancer (mCRPC)Release Date:Education Oncology All Closing Knowledge Gaps and Building Practical Skills in HRRm Testing for Metastatic Prostate CancerRelease Date:Education Oncology All Real World Evidence on the Impact of Early and Appropriate Use of Aztreonam-Avibactam (ATM-AVI)Release Date:Research Inflammation & Immunology Brazil, Chile, India, Italy, South Africa, Spain, United Kingdom Guideline Concordant Care and New Data for Patients with MIBC through la/mUCEducation Oncology USA Clinical Research Studies of Atirmociclib in HR+/HER2- and/or HER2+ Breast CancerRelease Date:Research Oncology Australia, Brazil, Canada, China, France, Germany, Italy, Japan, Korea, Mexico, Spain, Taiwan, USA, United Kingdom Quality Improvement Interventions to Enhance the Care of Patients Infected by MBL-CRE or S. maltophiliaRelease Date:Quality Improvement Inflammation & Immunology Australia, Chile, India, Italy, Spain, United Kingdom Advancing Real-World Evidence in Idiopathic Inflammatory Myopathies Through a German Disease RegistryRelease Date:Research Inflammation & Immunology Germany Real-World Evidence on Clinical Outcomes with ATM-AVI in Adult Patients with Stenotrophomonas maltophilia InfectionsRelease Date:Research Inflammation & Immunology China Real-World Evidence on Clinical Outcomes with Aztreonam-Avibactam (ATM-AVI) in Adult Patients with Limited Treatment OptionsRelease Date:Research Inflammation & Immunology China Tissue Penetration and Correlation with Clinical Outcomes of ATM-AVI in Adult Patients with Limited Treatment OptionsRelease Date:Research Inflammation & Immunology China -
Title Grant Type Focus Area Country Application Due Date 2023 Inflammatory Bowel Disease (IBD) FellowshipRelease Date:Fellowship Inflammation & Immunology USA Advances in the Management of Ulcerative Colitis (UC)Release Date:Education Inflammation & Immunology USA Knowledge Gaps in Managing High-Risk Patients and COVID-19Release Date:Education Hospital USA 2023 Bladder Cancer Canada-EMD Serono-Pfizer Quality Improvement Request for ProposalsRelease Date:Partner: Bladder Cancer Canada; EMD SeronoQuality Improvement Oncology Canada Relapsed/Refractory Multiple Myeloma (North America and Europe)Release Date:Education Oncology All Improving Metastatic Breast Cancer (mBC) Quality of Care and Equity in Latin AmericaRelease Date:Partner: Conquer Cancer, the ASCO FoundationQuality Improvement Oncology All Junior Investigator Global ATTR Amyloidosis Research ASPIRE (All countries except for the United States)Release Date:Research Rare Disease All Call for Independent Medical Education Grant Applications Oncology – Prostate CancerEducation Oncology USA Improving the Care of Patients Living with Metastatic Breast Cancer (mBC)Release Date:Partner: Rethink Breast CancerQuality Improvement Oncology Canada REI: Advisory Group for Patient-Reported Outcome Implementation in Vulnerable and Underserved PopulationsQuality Improvement Oncology USA Improving the quality of care of patients with urothelial cancerQuality Improvement Oncology Italy Mental Health in RheumatologyRelease Date:Quality Improvement Inflammation & Immunology Canada Optimizing Androgen Deprivation Therapy (ADT) in Advanced Prostate CancerEducation Oncology USA Optimizing Biomarker-Directed Therapy in Metastatic Colorectal CancerRelease Date:Partner: The National Comprehensive Cancer Network®, Fight Colorectal CancerQuality Improvement Oncology USA Addressing the Needs of Patients with Mental Health Issues and Dermatological Inflammatory ConditionsRelease Date:Quality Improvement Inflammation & Immunology Canada Quality Improvement Grants to Improve Identification and Management of Patients with ATTR-CMRelease Date:Quality Improvement Rare Disease Canada Transthyretin Amyloid Cardiomyopathy (ATTR-CM) ResearchRelease Date:Research Rare Disease USA Improving Treatment Environment and Survivorship for Multiple MyelomaRelease Date:Education Oncology Japan Improving Treatment Environment and Survivorship for LeukemiaRelease Date:Education Oncology Japan Advances in the Management of Ulcerative Colitis (UC) (Europe, Canada, Japan, South Korea, Australia, New Zealand, Israel)Release Date:Education Inflammation & Immunology All Increasing Awareness and Understanding of Transthyretin Cardiomyopathy (ATTR-CM)Release Date:Education Rare Disease USA Shared Decision-Making (SDM) for Patient Quality of Life in Cancer Treatment and Improving Access to BiologicsRelease Date:Education Oncology Japan Improvement of Treatment Environment of Immuno-Oncology Therapy for Urothelial CancerRelease Date:Quality Improvement Oncology Japan Optimizing the management of mBC HER2-patients / OncologyRelease Date:Quality Improvement Oncology Italy INNOVAtive Multi-disciplinary Clinical Management of INflammatory Diseases, 2023 IT INNOVA-MINDRelease Date:Quality Improvement Inflammation & Immunology Italy Quality Improvement in Pediatric Endocrinology FieldsRelease Date:Partner: The Japanese Society for Pediatric EndocrinologyQuality Improvement Rare Disease Japan Biomarker Testing / Lung CancerRelease Date:Education Oncology Japan Employment Support / Lung CancerRelease Date:Education Oncology Japan 2023 Oncology FellowshipRelease Date:Fellowship Oncology Canada Approaches to Implement Bispecific Antibodies into Clinical Practice, Increase Awareness and Improve Delivery of Quality of CareRelease Date:Partner: Myeloma CanadaQuality Improvement Oncology Canada Improving Health Equity via Clinical Trial Capability Development in ChinaRelease Date:Education Support for the Professions China Combination Therapy with Relugolix in the Treatment of Advanced Prostate CancerRelease Date:Partner: National Comprehensive Cancer Network; Myovant SciencesResearch Oncology USA Optimizing Women’s Health Conditions in CanadaRelease Date:Quality Improvement Internal Medicine Canada Women’s HealthRelease Date:Education Internal Medicine Canada Accelerating Advancements in Women’s HealthResearch Internal Medicine USA Implementing Rapid Turnaround Time for NGS Molecular Testing for Cancer Patients in Non-Academic and Community CentresRelease Date:Partner: Colorectal Cancer Canada and Thermo Fisher ScientificQuality Improvement Oncology Canada Transthyretin Cardiac Amyloidosis FellowshipRelease Date:Fellowship Rare Disease USA Project to Evaluate the Effectiveness of Elranatamab in the Treatment of Multiple MyelomaRelease Date:Partner: National Comprehensive Cancer NetworkResearch Oncology USA PARP-inhibitor Combination Treatments in Prostate CancerRelease Date:Education Oncology USA Approaches to Increase Equitable Access to and Delivery of Quality of Care with BsAb for Patients with Mutiple MyelomaRelease Date:Partner: International Myeloma FoundationQuality Improvement Oncology All Improving the care and outcomes of Canadians living with metastatic NSCLCRelease Date:Partner: Lung Health Foundation, Lung Cancer Canada, Quebec Lung AssociationQuality Improvement Oncology Canada Committing to Support Elderly Cancer PatientsRelease Date:Partner: Japan Society of Clinical OncologyEducation Oncology Japan Establishing System for Early Detection of Atrial Fibrillation and Prevention of Cardioembolic StrokeRelease Date:Quality Improvement Internal Medicine Japan Improving Early Detection and Appropriate Anticoagulant Therapy for Atrial FibrillationRelease Date:Education Internal Medicine Japan Promoting Understanding of Maternal ImmunizationRelease Date:Education Vaccines Japan Promoting Understanding of Pneumonia PreventionRelease Date:Education Vaccines Japan Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid CardiomyopathyRelease Date:Education Rare Disease USA Treatment Environment of Appropriate antiviral therapy for COVID-19 InfectionsRelease Date:Education Hospital Japan